Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 44.95 Million SEK | 36.94% |
| 2022 | 32.4 Million SEK | 61.37% |
| 2021 | 20.08 Million SEK | 74.19% |
| 2020 | 11.52 Million SEK | -59.6% |
| 2019 | 28.53 Million SEK | 14.5% |
| 2018 | 24.92 Million SEK | 31.98% |
| 2017 | 18.88 Million SEK | 16.06% |
| 2016 | 16.27 Million SEK | 59.59% |
| 2015 | 10.19 Million SEK | 795.08% |
| 2014 | 1.13 Million SEK | -61.71% |
| 2013 | 2.97 Million SEK | 489.91% |
| 2012 | -763 Thousand SEK | 24.68% |
| 2011 | -1.01 Million SEK | 60.48% |
| 2010 | -2.56 Million SEK | -147.09% |
| 2009 | 5.44 Million SEK | 515.81% |
| 2008 | -1.3 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 23.37 Million SEK | -16.44% |
| 2024 Q2 | 27.97 Million SEK | 172.04% |
| 2024 Q1 | 10.28 Million SEK | -24.97% |
| 2023 Q1 | 7.13 Million SEK | -18.67% |
| 2023 Q4 | 13.7 Million SEK | 14.94% |
| 2023 FY | 44.37 Million SEK | 36.94% |
| 2023 Q2 | 11.94 Million SEK | 67.55% |
| 2023 Q3 | 11.92 Million SEK | -0.22% |
| 2022 Q1 | 7.54 Million SEK | 37.36% |
| 2022 Q2 | 8.88 Million SEK | 17.75% |
| 2022 Q3 | 7.21 Million SEK | -18.81% |
| 2022 FY | 32.4 Million SEK | 61.37% |
| 2022 Q4 | 8.76 Million SEK | 21.58% |
| 2021 Q1 | 3.96 Million SEK | -54.23% |
| 2021 Q2 | 5.16 Million SEK | 30.22% |
| 2021 FY | 20.08 Million SEK | 74.19% |
| 2021 Q3 | 5.46 Million SEK | 5.85% |
| 2021 Q4 | 5.49 Million SEK | 0.51% |
| 2020 Q3 | 2.6 Million SEK | 275.03% |
| 2020 FY | 11.52 Million SEK | -59.6% |
| 2020 Q2 | -1.49 Million SEK | -131.41% |
| 2020 Q1 | 4.74 Million SEK | -30.73% |
| 2020 Q4 | 8.66 Million SEK | 232.09% |
| 2019 Q4 | 6.84 Million SEK | -21.41% |
| 2019 FY | 28.53 Million SEK | 14.5% |
| 2019 Q3 | 8.71 Million SEK | 57.71% |
| 2019 Q2 | 5.52 Million SEK | -25.87% |
| 2019 Q1 | 7.45 Million SEK | -1.21% |
| 2018 Q4 | 7.54 Million SEK | 95.06% |
| 2018 Q3 | 3.86 Million SEK | -29.33% |
| 2018 Q2 | 5.47 Million SEK | -31.94% |
| 2018 Q1 | 8.04 Million SEK | 24.07% |
| 2018 FY | 24.92 Million SEK | 31.98% |
| 2017 Q1 | 4.42 Million SEK | -10.58% |
| 2017 FY | 18.88 Million SEK | 16.06% |
| 2017 Q3 | 3.51 Million SEK | -21.45% |
| 2017 Q4 | 6.48 Million SEK | 84.56% |
| 2017 Q2 | 4.47 Million SEK | 1.09% |
| 2016 Q1 | 4.47 Million SEK | 29.32% |
| 2016 Q2 | 3.53 Million SEK | -21.15% |
| 2016 Q4 | 4.94 Million SEK | 49.04% |
| 2016 Q3 | 3.31 Million SEK | -6.01% |
| 2016 FY | 16.27 Million SEK | 59.59% |
| 2015 Q4 | 3.46 Million SEK | 135.99% |
| 2015 Q3 | 1.46 Million SEK | -43.29% |
| 2015 Q2 | 2.58 Million SEK | -3.43% |
| 2015 Q1 | 2.67 Million SEK | 91.08% |
| 2015 FY | 10.19 Million SEK | 795.08% |
| 2014 Q4 | 1.4 Million SEK | 15477.78% |
| 2014 Q1 | 121 Thousand SEK | -82.98% |
| 2014 Q2 | -393 Thousand SEK | -424.79% |
| 2014 Q3 | 9000.00 SEK | 102.29% |
| 2014 FY | 1.13 Million SEK | -61.71% |
| 2013 FY | 2.97 Million SEK | 489.91% |
| 2013 Q4 | 711 Thousand SEK | -57.17% |
| 2013 Q3 | 1.66 Million SEK | 222.87% |
| 2013 Q2 | -1.35 Million SEK | -169.28% |
| 2013 Q1 | 1.95 Million SEK | 134.94% |
| 2012 FY | -763 Thousand SEK | 24.68% |
| 2012 Q2 | -2.25 Million SEK | -1820.61% |
| 2012 Q3 | 532 Thousand SEK | 123.6% |
| 2012 Q4 | 830 Thousand SEK | 56.02% |
| 2012 Q1 | 131 Thousand SEK | 108.02% |
| 2011 Q4 | -1.63 Million SEK | -413.63% |
| 2011 Q1 | 1.16 Million SEK | 27.3% |
| 2011 FY | -1.01 Million SEK | 60.48% |
| 2011 Q3 | 521 Thousand SEK | 149.1% |
| 2011 Q2 | -1.06 Million SEK | -191.39% |
| 2010 Q2 | -2.17 Million SEK | -115.89% |
| 2010 Q1 | -1 Million SEK | -153.82% |
| 2010 Q3 | -294 Thousand SEK | 86.48% |
| 2010 Q4 | 912 Thousand SEK | 410.2% |
| 2010 FY | -2.56 Million SEK | -147.09% |
| 2009 Q1 | 3 Million SEK | 0.0% |
| 2009 Q3 | -687 Thousand SEK | -154.78% |
| 2009 Q2 | 1.25 Million SEK | -58.31% |
| 2009 FY | 5.44 Million SEK | 515.81% |
| 2009 Q4 | 1.87 Million SEK | 372.34% |
| 2008 Q2 | -2.69 Million SEK | -485.57% |
| 2008 Q1 | 700 Thousand SEK | 0.0% |
| 2008 FY | -1.3 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.55 Million SEK | 157.963% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 85.046% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 85.046% |
| Arcoma AB | 4.66 Million SEK | -864.635% |
| Bactiguard Holding AB (publ) | -131.93 Million SEK | 134.072% |
| BICO Group AB (publ) | -618.3 Million SEK | 107.27% |
| Boule Diagnostics AB (publ) | 39.27 Million SEK | -14.469% |
| CellaVision AB (publ) | 167.05 Million SEK | 73.091% |
| Clinical Laserthermia Systems AB (publ) | -65.93 Million SEK | 168.178% |
| Chordate Medical Holding AB (publ) | -29.57 Million SEK | 252.011% |
| C-Rad AB (publ) | 44.24 Million SEK | -1.6% |
| Duearity AB (publ) | -25.76 Million SEK | 274.483% |
| Dignitana AB (publ) | -15.02 Million SEK | 399.161% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 147.418% |
| Getinge AB (publ) | 3.81 Billion SEK | 98.821% |
| Scandinavian Real Heart AB (Publ) | -68.44 Million SEK | 165.675% |
| Iconovo AB (publ) | -45.77 Million SEK | 198.198% |
| Integrum AB (publ) | 6.51 Million SEK | -590.259% |
| Luxbright AB (publ) | -25.8 Million SEK | 274.203% |
| Mentice AB (publ) | -679 Thousand SEK | 6720.324% |
| OssDsign AB (publ) | -91.95 Million SEK | 148.884% |
| Paxman AB (publ) | 12.61 Million SEK | -256.225% |
| Promimic AB (publ) | -9.11 Million SEK | 593.003% |
| Qlife Holding AB (publ) | -168.69 Million SEK | 126.647% |
| SciBase Holding AB (publ) | -53.93 Million SEK | 183.339% |
| ScandiDos AB (publ) | -13.48 Million SEK | 433.398% |
| Sectra AB (publ) | 518.49 Million SEK | 91.33% |
| Sedana Medical AB (publ) | -65.54 Million SEK | 168.58% |
| Senzime AB (publ) | -133.74 Million SEK | 133.61% |
| SpectraCure AB (publ) | -21.35 Million SEK | 310.538% |
| Vitrolife AB (publ) | -3.58 Billion SEK | 101.252% |
| Xvivo Perfusion AB (publ) | 38.5 Million SEK | -16.74% |